We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HNI:NYSEHNI Corporation Analysis

Data as of 2026-05-21 - not real-time

$30.44

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

HNI’s stock is trading at $30.44, well below its 20‑day (34.05), 50‑day (35.14) and 200‑day (42.07) simple moving averages, signaling a bearish technical backdrop. The MACD histogram remains negative and the RSI sits at 35, hinting at oversold conditions but also confirming limited upside momentum. Valuation metrics are extreme: a trailing P/E of 112× contrasts sharply with a forward P/E of 6.3× and a discounted cash‑flow fair value of just $8.39, implying the market is pricing in a substantial premium. Dividend sustainability is doubtful given a 4.6% yield paired with a payout ratio exceeding 500%, and the company’s leverage is high (debt‑to‑equity ~97%).
Despite the technical weakness, the latest quarter showed a 125% year‑over‑year revenue surge to $1.35 billion and non‑GAAP EPS beat expectations, driven by cost controls and pricing actions in the Workplace Furnishings segment. However, operating margins remain thin (≈1.5%) and free cash flow is negative, while the balance sheet carries $1.73 billion of debt. The mixed earnings narrative, combined with elevated 30‑day volatility (≈48%) and a beta near 1, suggests that any upside will be contingent on sustaining growth and improving cash generation.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish technical indicators (price below all SMAs, negative MACD)
  • Extreme valuation gap versus DCF fair value
  • Unsustainable dividend payout

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong quarterly revenue growth and EPS beat
  • Improving forward earnings outlook (forward EPS 4.84)
  • High leverage and thin operating margins

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Persistently high valuation multiples
  • Debt burden and negative free cash flow
  • Volatile earnings and sector cyclicality

Key Metrics & Analysis

Financial Health

Revenue Growth124.70%
Profit Margin0.04%
P/E Ratio112.7
ROE0.12%
ROA4.34%
Debt/Equity97.41
P/B Ratio1.2
Op. Cash Flow$91.9M
Free Cash Flow$-5450000

Technical Analysis

TrendBearish
RSI35.6
Support$28.93
Resistance$37.99
MA 20$34.05
MA 50$35.14
MA 200$42.07
MACDBearish
VolumeIncreasing
Fear & Greed Index90.29

Valuation

Fair Value$8.39
Target Price$69.00
Upside/Downside126.68%
GradeOvervalued
TypeGrowth
Dividend Yield4.60%

Risk Assessment

Beta1.00
Volatility48.12%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.